When was Recursion Pharmaceuticals founded?

Recursion Pharmaceuticals was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is Recursion Pharmaceuticals located?

Recursion Pharmaceuticals is headquartered in New York, United States. It is registered at Salt Lake City, Utah.

Who is the current CEO of Recursion Pharmaceuticals?

Chris Gibson of Recursion Pharmaceuticals. They have also founded 1 company and are angel investors in 7 startups, including .

How many employees does Recursion Pharmaceuticals have?

As of Apr 30, 2026, the latest employee count at Recursion Pharmaceuticals is 2.

Is Recursion Pharmaceuticals a funded company?

Recursion Pharmaceuticals is a funded company, having raised a total of $452M across 19 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 01, 2014.

When was the latest funding round of Recursion Pharmaceuticals?

Recursion Pharmaceuticals' latest funding was a $***** Post IPO round on Jul 12, 2023, with participation from 1 investor.

What is the annual revenue of Recursion Pharmaceuticals?

Annual revenue of Recursion Pharmaceuticals is $74.7M as on Dec 31, 2025.

Where does Recursion Pharmaceuticals rank among its competitors?

Recursion Pharmaceuticals ranks 1st amongst 142 active competitors, of which 62 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was XtalPi, which secured $268M in Sep, 2025.

Who are the top competitors of Recursion Pharmaceuticals?

Recursion Pharmaceuticals' top competitors include XtalPi, Schrodinger and Healx. Among them, XtalPi secured the most recent funding round in September, 2025.

Recursion Pharmaceuticals - 2026 Company Profile, Team, Funding, Competitors & Financials

Recursion Pharmaceuticals is a public company based in New York (United States), founded in 2013 by Chris Gibson and Dean Li. It operates as an AI-enabled drug discovery and development platform for novel therapeutics. Recursion Pharmaceuticals has raised $452M in funding from investors like Felicis Ventures, DCVC and Advantage Capital. The company has 142 active competitors, including 62 funded and 10 that have exited. Its top competitors include companies like XtalPi, Schrodinger and Healx.

Company Details

AI-enabled drug discovery and development platform for novel therapeutics. It focuses on identifying new targets and designing optimized molecules. The platform utilizes biological and chemical datasets, machine learning models, and a supercomputer to accelerate the discovery of medicines. It aims to improve the speed and efficiency of drug development for conditions with high unmet needs, including cancers and rare diseases. The company also forms strategic partnerships to expand its impact on patients.

Website: recursion.com
Social
Email ID: *****@recursion.com
Phone Number: +1 **********
Registered Address: Salt Lake City, Utah

Key Metrics

Founded Year

2013

Location

New York, United States

Stage

Public

Total Funding

$452M in 19 rounds

Latest Funding Round

Post IPO, Jul 12, 2023, $*****

Investors

Felicis Ventures & 47 more

Ranked

1^st among 142 active competitors

Annual Revenue

$74.7M as on Dec 31, 2025

Employee Count

2 as on Apr 30, 2026

Investment & Acquisitions

Exscientia & 3 more

Similar Companies

Innovaccer & 2436 more

Exit Details

Public

View Recursion Pharmaceuticals' full profile

Recursion Pharmaceuticals is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Recursion Pharmaceuticals, Inc. CIN: 6727635 , United States, Active	Feb 08, 2023	-	-	-
RECURSION PHARMACEUTICALS, INC. CIN: 1601830 , United States, Active	Apr 01, 2014	$74.7M (As on Dec 31, 2025)	400 (As on Dec 31, 2021)	-
RECURSION PHARMACEUTICALS LLC CIN: 464099738 , United States, Active	Dec 31, 1999	-	453 (As on Dec 31, 2024)	-
Recursion Pharmaceuticals, LLC CIN: 1601830 , United States, Active		$1 - $1M (As on Dec 04, 2015)	-	-

Recursion Pharmaceuticals got listed on Apr 16, 2021.

Click here to take a look at Recursion Pharmaceuticals's IPO in detail

Recursion Pharmaceuticals has raised a total funding of $452M over 19 rounds. Its first funding round was on Jan 01, 2014. Its latest funding round was a Post IPO round on Jul 12, 2023 for $*****. 1 investor participated in its latest round. Recursion Pharmaceuticals has 48 institutional investors.

Here is the list of recent funding rounds of Recursion Pharmaceuticals:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 12, 2023	5313103	Post IPO	5077957	3934580	9164900	3533258
Oct 25, 2022	7211037	Post IPO	9327066	3659636	9290652	Kinnevik & 4 more
Sep 09, 2020	6403600	Series D	8409157	3913903	Leaps by Bayer & 14 more	Laurion Capital

Access funding benchmarks and valuations. Sign up today!

View details of Recursion Pharmaceuticals's funding rounds and investors

The founders of Recursion Pharmaceuticals are Chris Gibson and Dean Li. Chris Gibson is the CEO of Recursion Pharmaceuticals.

Here are the details of Recursion Pharmaceuticals' key team members:

Chris Gibson: Co-Founder and CEO of Recursion Pharmaceuticals. They are also an angel investor in 7 startups.
Dean Li: Co-Founder and Board Member of Recursion Pharmaceuticals.

View details of Recursion Pharmaceuticals's Founder profiles and Board Members

Recursion Pharmaceuticals' employee count trend

Recursion Pharmaceuticals has 2 employees as of Apr 26. Here is Recursion Pharmaceuticals's employee count trend over the years:

Employee count trend for Recursion Pharmaceuticals

Uncover Recursion Pharmaceuticals' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Recursion Pharmaceuticals include XtalPi, Schrodinger and Healx. Here is the list of Top 10 competitors of Recursion Pharmaceuticals, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Recursion Pharmaceuticals 2013, New York (United States), Public	AI-enabled drug discovery and development platform for novel therapeutics	$452M	HTIF, Square 1 Bank & 46 others	72/100
2nd	XtalPi 2014, Cambridge (United States), Public	AI-based drug research and development company	$785M	SoftBank Vision Fund, Orbimed & 25 others	67/100
3rd	Schrodinger 1990, New York City (United States), Acquired	Provider of a web-based simulation and modelling tool	$162M	Gates Foundation, WuXi AppTec & 16 others	66/100
4th	Healx 2014, Cambridge (United Kingdom), Series C	AI-powered drug discovery platform to treat rare diseases	$115M	Atomico, R42 Group & 17 others	64/100
5th	METiS Therapeutics 2017, Cambridge (United States), Series B	Provider of an AI-assisted platform for drug discovery and development	$252M	Sequoia Capital China, Luminous Ventures ... & 13 others	63/100
6th	Xaira 2023, San Francisco (United States), Series D	AI-enabled platform for drug discovery and development	$1B	Arch Venture Partners, Foresite Labs & 11 others	63/100
7th	Valo Health 2019, Boston (United States), Series B	AI-powered platform for drug discovery and development	$450M	PSP Investments, Koch Disruptive Technologies ... & 7 others	62/100
8th	Aqemia 2019, Paris (France), Series A	Provider of an AI and quantum physics to discover therapeutic molecules	$103M	Eurazeo, Elaia & 4 others	62/100
9th	In Silico 2014, Cambridge (United States), Public	AI-enabled bioinformatics platform for drug discovery and biomarker development	$510M	Qiming Venture Partners, Warburg Pincus & 36 others	62/100
10th	Isomorphic Labs 2021, London (United Kingdom), Series D	AI-driven platform to accelerate drug discovery process	$600M	Thrive Capital, Alphabet & 1 others	62/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Recursion Pharmaceuticals's competitors? Click here to see the top ones

Recursion Pharmaceuticals has not made any investments yet. Recursion Pharmaceuticals has made 4 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Oct 10, 2024	Acquisition	Exscientia	2012	Oxford (United Kingdom)
May 08, 2023	Acquisition	Cyclica	2013	Toronto (Canada)
May 08, 2023	Acquisition	Valence Labs	2017	Montreal (Canada)

Want to know more about where corporates are investing? Sign up today!

See all acquisitions by Recursion Pharmaceuticals

Media has covered Recursion Pharmaceuticals for a total of 26 events in the last 1 year, 11 of them have been about company updates and 4 about people movement.